Inhibition of cancer growth by resveratrol is related to its low bioavailability.
about
What is new for an old molecule? Systematic review and recommendations on the use of resveratrolAssociation between pterostilbene and quercetin inhibits metastatic activity of B16 melanomaResveratrol and clinical trials: the crossroad from in vitro studies to human evidenceResveratrol: a review of preclinical studies for human cancer preventionPhytochemicals for the Management of MelanomaRole of Natural Stilbenes in the Prevention of CancerAutophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cellsResveratrol inhibits protein translation in hepatic cellsPterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancerChanges in white adipose tissue metabolism induced by resveratrol in ratsResveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosisThe prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells.Therapeutic Effects of Phytochemicals and Medicinal Herbs on Depression.Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease.Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged miceNew delivery systems to improve the bioavailability of resveratrol.Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanismResveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth.Design and synthesis of compounds that extend yeast replicative lifespan.Pharmacokinetics of selected stilbenes: rhapontigenin, piceatannol and pinosylvin in rats.Resveratrol: challenges in translation to the clinic--a critical discussion.Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytesGrape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer.Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells.The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.Development of a lozenge for oral transmucosal delivery of trans-resveratrol in humans: proof of conceptAnti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitroBotanicals for the prevention and treatment of cutaneous melanoma.Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparisonBioactivation of Phytoestrogens: Intestinal Bacteria and Health.Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cellsResveratrol Inhibits the Invasion of Glioblastoma-Initiating Cells via Down-Regulation of the PI3K/Akt/NF-κB Signaling PathwayResveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut MicrobiotaDNA breakage induced by piceatannol and copper(II): Mechanism and anticancer properties.Benzo[a]pyrene-induced cytochrome P450 1A and DNA binding in cultured trout hepatocytes - inhibition by plant polyphenols.Inhibition of Na⁺-H⁺ exchange as a mechanism of rapid cardioprotection by resveratrol.Dose-dependent short- and long-term effects of ionizing irradiation on neural stem cells in murine hippocampal tissue cultures: neuroprotective potential of resveratrol
P2860
Q21089966-414478E2-D117-4605-9E3F-9E75FA79E3FFQ24549889-CB6B6E6F-69B2-4A84-A3B9-1FEA10A5C9D3Q24618313-E3F413D2-FEA8-4FB5-82A4-7F46312F6FA1Q24675163-CB89F773-1E42-4FD4-92B0-C4BC7CD6C4E3Q26766708-19332E1C-D37D-409C-BD33-7C1FC88B03D2Q26769976-68A7BA89-CCC9-4991-A3D9-DC40C5771EE3Q28478548-1C48DE45-8D44-496E-B9DA-2849CE115522Q28478644-63329EF2-0B54-45AF-905B-30FDEEF47E79Q28487488-FE629A76-5DDD-43AA-AD2B-3D25EE1B3484Q28567175-28D91896-4D13-44F9-8117-6C01151DD84AQ28831178-41E5AB64-E70A-4916-92A6-349F253407D9Q33476510-B917AAE5-9185-43F7-BC10-9A2BF00D4648Q33630966-EB642E25-DA99-400E-9F70-C0721CC18B9AQ33850299-208781DF-7397-467E-BBC4-952BC95241EAQ33944063-888A2FAE-94AA-4DA9-AFD4-2F09BE375BF1Q33991493-89E8DCC8-6677-46D4-8330-524519557835Q34192059-7605592F-5BBB-4F1C-9372-F29309117031Q34408186-B59EF0F4-D56F-4D25-B0ED-A488796D585AQ34571083-99207AD5-7984-40D3-96B8-0E9E3CB06294Q34573125-EC958E7B-C9BA-472D-B501-F338A02E6AEEQ34585391-AAADAD3B-C003-4170-BE3F-DFE06771ABC8Q34673721-796FC14F-E64E-4D1D-87C8-04ECF925D913Q34744832-48FDEE41-4A5B-4E86-A111-DCFA4771F7F2Q34855692-17AEBBD2-7284-4136-9507-36F24D17A39AQ34880559-C6E0C474-51A5-4B09-94EA-51991C25ED83Q34997000-17116B89-DB06-4EEC-A7A8-AC4363346665Q35036502-64E737ED-E648-4BD3-8CD9-A5A50BA6CFAAQ35108724-438D3BAB-C452-41E1-A220-C5E9B4E8B822Q35149578-8D905323-CF49-41D2-826A-16B7FA32C1CBQ35172747-43961783-984C-4975-AF8A-1A6D0C071A92Q35445753-6B082113-751B-445F-9B79-9616BB8D9BA1Q35596030-3A1082BB-5E4D-40CD-A347-CA81E908D274Q35607205-8CCA1000-D931-45F9-BF96-F676F6B15734Q35668666-ABE92281-AC33-4432-97DA-723019EE1BB2Q35808894-AE61D05F-DF2D-48E6-BF99-0EFF66BD0578Q35980540-900A894F-500C-4763-812E-14530CA0241BQ36075894-75FBB4BA-12AD-430C-BE59-70CAE128E16EQ36082444-B3D3B8F3-C748-46EB-B6ED-DDB2BABE4152Q36110568-03A029DF-EF2A-47F8-9C24-D0AF95F75638Q36174351-6C96C592-5DCC-43EB-8751-3B9D6B73D69A
P2860
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@ast
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@en
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@nl
type
label
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@ast
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@en
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@nl
prefLabel
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@ast
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@en
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@nl
P2093
P1476
Inhibition of cancer growth by resveratrol is related to its low bioavailability.
@en
P2093
Angel Ortega
Elena Obrador
Ignacio Medina
Jose M Estrela
M Carmen Baño
Miguel Asensi
P304
P356
10.1016/S0891-5849(02)00911-5
P577
2002-08-01T00:00:00Z